Used primarily in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs. It plays a significant role in the development of compounds targeting protein degradation pathways, particularly cereblon E3 ubiquitin ligase modulators. These modulators are investigated for their potential in treating various cancers, including multiple myeloma and other hematological malignancies. The compound's structure enables selective binding to biological targets, enhancing the degradation of disease-causing proteins. It is also explored in the design of novel therapeutics for inflammatory and autoimmune disorders due to its ability to modulate cellular signaling pathways.